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Humphrey Center researcher looks for 
clues to cancer causes in bacterial DNA 
As technology advances and with it the 
increasing danger of exposure to harmful 
chemicals, scientists continue to be 
intrigued by the suspected relationship 
between environmental toxins and cancer. 
Members of the Hubert H. Humphrey 
Cancer Research Center are looking for 
clues to the cause of cancer in the DNA of 
bacteria. According to Patricia L. Foster, 
Ph.D., an assistant professor of 
environmental health at Boston University 
School of Public Health, understanding 
how chemical carcinogens induce 
mutations may shed light on the origins of 
cancer. 
"When animals or cells are exposed to a 
carcinogen, this carcinogen interacts with 
and causes damage to the DNA, and is one 
of the initiating events that eventually 
leads to cancer," explains Dr. Foster. "I 
am involved in studying what types of 
damage occur in bacteria when they are ex-
posed to various chemicals, how the or-
ganism reponds to them and what the con-
sequences are." 
Dr. Foster works primarily with the bac-
terium Escherichia coli. Bacteria act as 
ideal models to study because they respond 
to chemical carcinogens by developing 
mutations, although they do not actually 
develop cancer. Other advantages of using 
bacteria as models are that so much 
knowledge already exists about bacteria, 
and researchers can manipulate them in 
various ways. "It's a much simpler sys-
tem," says Dr. Foster. "We can learn a lot 
more about what's going on a lot faster." 
The research procedure is relatively 
simple. Dr. Foster generates bacteria that 
have various defects in their abilities to 
repair their DNA, and then exposes them to 
a particular carcinogenic agent. The 
endpoint is to document what mutations in 
the cells result. "Because I know exactly 
which enzyme is not working, I can figure 
out step-by-step the entire pathway, from 
exposure to final mutation," says Dr. 
Foster. "When this knowledge is put 
together with the biochemistry of the agent 
and the biology of other organisms, you 
can begin to understand the effect of this 
particular compound. For instance, if 
human beings have the same enzyme in 
their livers, they might be able to handle ex-
posure to the same chemical compound." 
continued on page 3 Patricia L. Foster, Ph.D., at work in her lab. 
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Possible link found between oral contraceptives, breast cancer 
Since oral contraceptives became widely 
available in the 1960s, researchers have 
conducted numerous studies to explore 
whether using oral contraceptives increases 
the risk of breast cancer. A recent study 
conducted by Hubert H. Humphrey Cancer 
Research Center investigators at Boston 
University School of Medicine suggests 
that women under the age of 45 who use 
oral contraceptives may be at increased risk. 
The senior investigators of the study are 
Samuel Shapiro, M.B.B.Ch., a research 
professor of public health (epidemiology) 
and director of Boston University School of 
Medicine's Slone Epidemiology Unit, and 
Lynn Rosenberg, Sc.D., an associate profes-
sor of public health (epidemiology) and as-
sistant director of the Unit. Donald Miller, 
Sc.D., is the first author of the study, 
which was completed while he served as 
an epidemiologist with the Slone Unit. 
The results were made public at a recent 
federal Food and Drug Administration 
hearing on breast cancer and oral con-
traceptives, and were published in the 
February issue of Iho American Journal of 
Epidemiology. 
"Any study published now on this sub-
ject is controversial, because the findings 
of the different studies not only conflict 
with each other, but later findings from 
continuing studies conflict with earlier find-
ings," says Dr. Rosenberg. "Our study has 
continued on page 2 
2 HUMPHREY CENTER NEWS 
Contraceptives 
continued from page 1 
been in progress since 1976. We have 
published twice before on the data, and in 
each case, the results were null. Our most 
recent data are positive. The same thing 
has happened in an ongoing study con-
ducted in Great Britain, where earlier 
results were null and recent results were 
positive." 
The case-control study was conducted 
to assess the relationship between the use 
of oral contraceptives and the risk of breast 
cancer in women under the age of 45. The 
researchers compared cases and controls 
from hospitals in Boston, New York, 
Philadelphia and Baltimore. The 407 cases 
were women aged 25 to 44, with a diag-
nosis of breast cancer made no more than 
six months before admission, and with no 
previous history of cancer. They were 
compared to 424 controls, women within 
the same age range, who were admitted for 
nongynecologic, nonmalignant conditions 
judged to be unrelated to oral contraceptive 
use, and with no history of cancer. 
To provide information on the relation-
ship between oral contraceptives and the 
risk of breast cancer, the investigators es-
timated the relative risk of breast cancer. 
"We were interested in comparing the risk 
of breast cancer in women who had used 
oral contraceptives to the risk in women 
who have not used them," says Dr. Rosen-
berg. "If the relative risk equals one, that 
means there is no difference in risk." In es-
timating relative risk, the researchers took 
into account "confounding" variables. 
These variables, which included age, life-
style, geographic area, reproductive history 
and year of interview, might have distorted 
a relationship between oral contraceptive 
use and breast cancer. 
In the earlier studies, the researchers 
found that the histories of oral-contracep-
tive use of the cases and controls were very 
similar. In the recent study, the cases were 
more likely to have used oral contracep-
tives for longer durations than controls. 
This translated into an estimated relative 
risk of 2.0 for women who have used oral 
contraceptives for less than 10 years, while 
for those women who had used oral con-
traceptives for 10 or more years the es-
timated relative risk was 4.1. The latter es-
timate was based on small numbers of 
women, however. "If these results are cor-
rect, this implies that the risk of breast can-
cer is doubled, or more, in oral-contracep-
tive users as opposed to nonusers," says 
Dr. Rosenberg. 
Dr. Rosenberg adds that the hypothesis 
that oral contraceptives may cause breast 
cancer has become so well known to the 
general public that researchers must con-
sider so-called "information bias" as an ex-
planation of positive findings. "Since 
many of the women with breast cancer 
whom we interview may know the 
hypothesis, they may be more likely to 
search their memories and provide more 
complete information than controls. Even 
if the hypothesis is not known, cases might 
remember better or differently than the con-
trols. Medical records of contraceptive use 
in the distant past do not exist, and we 
have had to rely on patients' memories of 
oral contraceptive use. Information bias 
cannot be ruled out." 
Drs. Shapiro and Rosenberg are continu-
ing to pursue additional information by in-
itiating further studies. "We are analyzing 
a large existing data base on older cases 
and controls, women aged 45 to 59, to see 
whether oral contraceptive use and breast 
cancer are associated in this age group," 
says Dr. Rosenberg. "We also are continu-
ing the study from which the data on these 
and younger women were collected. Thus, 
we will be studying further younger and 
older cases and controls." 
Drs. Shapiro and Rosenberg also hope 
to conduct a follow-up study of young 
women who would have had the oppor-
tunity to use oral contraceptives at younger 
Ann Aschengau, Sc.D., a member of the 
Hubert H. Humphrey Cancer Research 
Center and an assistant professor of public 
health at the School of Public Health, is the 
principal investigator of a two-year, 
$500,000 study on the causes of elevated 
cancer rates in permanent residents of 
upper Cape Cod. The study is funded by 
the Massachusetts Department of Public 
Health. 
According to the most recent statistics, 
the overall cancer rates in the towns of 
Barnstable, Bourne, Falmouth, Mashpee 
and Sandwich are 17 percent higher than 
the statewide norm. The researchers wiU 
study 1,200 cancer cases reported in the 
area between 1982 and 1985, along with 
1,500 controls from the same geographic 
area. Seven types of cancer will be 
studied: breast, colon-rectal, lung, bladder, 
kidney and pancreatic, as well as leukemia. 
A number of possible factors will be ex-
plored, including exposure to air and water 
pollution; radio waves generated by a near-
by military radar facility; electromagnetic 
radiation from powerlines and trans-
formers; and such lifestyle factors as smok-
Lynn Rosenberg, ScD., continues to study the 
relationship between the 'pUV and breast 
cancer. (Photo by Bradford F. Herzog) 
ages. Dr. Rosenberg believes further 
studies of breast cancer and contraceptive 
use are urgently needed. "The positive 
studies have raised some concern and there 
is a growing consensus for the need to sup-
port further research," she says. 
ing and alcohol use. Although data will not 
be released until the end of the study, 
public meetings will be held to inform con-
cerned residents of the study's progress. 
Humphrey Center member John R. 
Murphy, Ph. D., a professor of medicine, 
biochemistry and microbiology and chief 
of biomolecular medicine at the University 
Hospital, is the principal investigator of a 
five-year, $2.3-million cooperative agree-
ment from the National Cancer Institute 
(NCI) to continue to study a new class of 
drugs that attacks specific leukemias and 
lymphomas. The cooperative agreement 
award is part of the new NCI-sponsored Na-
tional Cooperative Drug Discovery Group 
program, which encourages interaction 
among academic and commercial interests 
in partnership with the NCI to discover 
new strategies for the treatment of cancer. 
Also involved in the study is Hubert H. 
Humphrey Cancer Research Center mem-
ber Ronald McCaffrey, M.D., a professor 
of medicine and chief of medical oncology 
at the University Hospital, as well as re-
searchers at Beth Israel Hospital and 
Brigham and Women's Hospital in Boston. 
IN BRIEF 
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Humphrey Center member Arnold E. Reif, DSc, second from left, a research professor of 
pathology, recently received a $7,000 grant from Aid for Cancer Research (ACR) to support his 
research on the immunogenicity of tumors for use in experimental immunotherapy. Shown here 
with Dr. Reif, from left to right, are ACR members Phyllis Frank, Naomi Wainer, Lois Weinman 
and Cheryl Bloom, president. ACR is a volunteer group made up of 25 women who raise funds to 
help support cancer research in the Boston area. (Photo by David Keough, Educational Media, 
BUSM) 
DNA 
continued from page 1 
Dr. Foster's research involves the use 
of several chemicals that are known car-
cinogens, and she is studying their effect 
on E. coli DNA. She chooses the chemi-
cals in her research for two reasons. One 
is that many serve as good models and are 
easy to handle in the laboratory; another is 
that they are important environmental car-
cinogens. The chemicals under study in-
clude aflatoxin and insecticide ethylene 
dibromide (EDB). 
"Aflatoxin is produced by a fungus that 
grows on rice, com and peanuts under hot 
and humid weather conditions," explains 
Dr. Foster. "Apparently, last summer 
much of the com in the Midwest was in-
fected. There now is some concem that 
the aflatoxin levels in the com may be too 
high for human consumption." While 
until now aflatoxin has not been a major 
problem in the U.S., it is a major health 
issue and has been suspected as a primary 
cause of liver cancer in other parts of the 
world, including China and Africa. 
Dr. Foster was the principal inves-
tigator in a recent study published in Muta-
tion Research on the mutagenicity of the 
EDB to E. coli DNA and how the bacteria 
repair the damage. "This pesticide now is 
banned from use in this country, but we 
still import fmit that has been treated with 
EDB," she wams. "We already knew that 
this chemical is extremely potent. Our 
recent findings indicate that even though 
the bacteria do not have the enzymes to 
metabolize EDB the way that humans do, 
the compound still is highly mutagenic to 
the bacteria. Another important aspect of 
EDB that we have discovered is that under 
certain circumstances, the bacteria do not 
readily repair the damage caused by the 
chemical because the damage stays hidden 
from the ceUs. This means that the chemi-
cal may be more dangerous than we pre-
viously thought. These findings would not 
have been uncovered if we were working 
with a higher organism." 
Another chemical substance being 
studied by Dr. Foster is the chemo-
therapeutic agent cis-diam-minedi-
chloroplatinum-II (cis-Pt). Since 
chemotherapeutic agents themselves are 
carcinogenic, she is working to uncover 
how to improve its chemotherapeutic 
qualities and reduce its carcinogenicity. 
This would be particularly beneficial for 
children who receive chemotherapy as 
treatment for leukemia and may develop 
cancer later on as a result of this exposure. 
Dr. Foster emphasizes that a major 
focus of her research is the pursuit of basic 
knowledge about the bacteria, which may 
shed light on DNA damage and repair sys-
tems. "The more we find out about the 
way these organisms work, the more we 
will ultimately understand. Basic research 
is important." 
The next step is to apply this informa-
tion to higher organisms, including 
humans, in order to learn more about the 
origins of cancer. "My feeling is that the 
kinds of damage that arise in DNA are not 
specific to any particular organism," says 
Dr. Foster. "There is quite a bit of ex-
perimental evidence indicating that the 
DNA is essentially the same and the kinds 
of DNA damage you see in bacteria are ex-
actly the same as those in higher or-
ganisms. So the research is aimed at un-
derstanding what damage there is and how 
the damage is repaired." This is impor-
tant, she adds, because much of the DNA 
repair activity is the same in bacteria as in 
mammals. 
QUESTIONS... 
Answer to question on back panel. 
A . There are over 5,000,000 Amer-
icans alive today who have a history of 
cancer, 3,000,000 of whom were 
diagnosed five or more years ago. Most 
of these 3,000,000 can be considered 
cured, while others still have evidence of 
cancer. The term "cured" means that a 
patient has no clinical evidence of the 
presence of cancer and is considered to 
have the same life expectancy as a person 
who never had the disease. 
The decision as to when a patient may 
be considered cured is one that must be 
made by the physician after examining 
the individud patient. For most forms of 
cancer, five years without symptoms fol-
lowing treatment is the accepted time. 
However, some patients can be con-
sidered cured after one year, others after 
three years, whereas some have to be fol-
lowed much longer than five years. 
4 HUMPHREY CENTER NEWS 
CANCER NOTES 
CANCER NOTE: Some cancers, not 
all, can be prevented. Most lung cancers 
are caused by cigarette smoking, and 
most skin cancers by frequent 
overexposure to direct sunlight. These 
cancers can be prevented by avoiding 
their causes. Certain cancers caused by 
occupational-environmental factors can 
be prevented by eliminating or reducing 
contact with carcinogenic agents. 
CANCER NOTE: More than 500,000 
cases of skin cancer are reported each 
year, the vast majority of which are 
highly curable basal or squamous cell 
cancers. The most serious skin cancer is 
malignant melanoma, which strikes 
about 27,000 persons each year. The 
incidence of melanoma is increasing at 
the rate of 3.4 percent per year. 
CANCER NOTE: Improvements in 
cancer treatment have made more 
conservative surgical management of 
some cancers possible. In the early stages 
of cancer of the larynx, many patients 
have been able to retain their larynx and 
their voice; in colorectal cancer, fewer 
permanent colostomies are needed, and 
the surgery required in many cases of 
breast cancer often is more limited. 
CANCER NOTE: The American 
Cancer Society recommends eating more 
high-fiber foods, such as whole grain 
cereals, fruits and vegetables. Studies 
suggest that diets high in fiber may help 
to reduce the risk of colon cancer. 
Furthermore, foods high in fiber content 
are a wholesome substitute for foods high 
in fat. 
The Humphrey Cancer Center News is 
published for the Hubert H. Humphrey 
Cancer Research Center of Boston 
University School of Medicine by the 
Office of Publication Services, Boston 
University Medical Center. Humphrey 
Center Director, Herbert H. Wotiz, Ph.D.; 
Editor, Michael Rabin; Writer, Sarita 
Ledani. "Cancer Notes" information is 
provided courtesy of the American 
Cancer Society. 
How many people alive 
today have ever had cancer? 
ANSWER ON PAGE 3 
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